Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.7645 USD | -5.95% | +2.80% | -62.52% |
Apr. 15 | Nature Medicine Publishes Interim Results from Gritstone Bio's Phase 1/2 Study of "Off-The-Shelf" Neoantigen Vaccine Platform | CI |
Apr. 02 | Top Midday Decliners | MT |
Financials (USD)
Sales 2024 * | 35.6M | Sales 2025 * | 64.31M | Capitalization | 81.34M |
---|---|---|---|---|---|
Net income 2024 * | -134M | Net income 2025 * | -132M | EV / Sales 2024 * | 3.83 x |
Net Debt 2024 * | 54.84M | Net Debt 2025 * | 63.58M | EV / Sales 2025 * | 2.25 x |
P/E ratio 2024 * |
-0.71
x | P/E ratio 2025 * |
-0.81
x | Employees | 231 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.7% |
Latest transcript on Gritstone bio, Inc.
1 day | -5.95% | ||
1 week | +2.80% | ||
Current month | -70.25% | ||
1 month | -71.58% | ||
3 months | -73.18% | ||
6 months | -59.97% | ||
Current year | -62.52% |
Managers | Title | Age | Since |
---|---|---|---|
Andrew Allen
FOU | Founder | 57 | 15-07-31 |
Director of Finance/CFO | 44 | 21-06-22 | |
Karin Jooss
CTO | Chief Tech/Sci/R&D Officer | 59 | 16-04-12 |
Members of the board | Title | Age | Since |
---|---|---|---|
Andrew Allen
FOU | Founder | 57 | 15-07-31 |
Elaine Jones
CHM | Chairman | 69 | 19-09-11 |
Lawrence Corey
BRD | Director/Board Member | 77 | 22-08-11 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.02% | 0 M€ | 0.00% | - | |
0.02% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 0.7645 | -5.95% | 1,068,630 |
24-04-24 | 0.8129 | +10.06% | 1,886,214 |
24-04-23 | 0.7386 | -0.93% | 2,411,711 |
24-04-22 | 0.7455 | +1.21% | 3,390,234 |
24-04-19 | 0.7366 | -0.95% | 1,532,645 |
Delayed Quote Nasdaq, April 25, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-62.52% | 81.34M | |
-4.68% | 87.53B | |
+2.63% | 40.42B | |
-21.76% | 29.48B | |
+58.56% | 25.43B | |
-14.78% | 15.59B | |
-18.49% | 11.49B | |
-15.61% | 11.1B | |
-44.02% | 11.3B | |
+5.17% | 8.75B |
- Stock Market
- Equities
- GRTS Stock